BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30616803)

  • 21. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 22. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
    Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elective lymphadenectomy during salvage for locally recurrent head and neck squamous cell carcinoma after radiation.
    Prendes BL; Aubin-Pouliot A; Egbert N; Ryan WR
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):462-7. PubMed ID: 24894423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
    Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
    Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction.
    Hafström A; Wahlberg P; Klasson S; Greiff L; Sjövall J
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2953-2964. PubMed ID: 36897366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma.
    Kozak MM; Shah J; Chen M; Schaberg K; von Eyben R; Chen JJ; Bui T; Kong C; Kaplan M; Divi V; Hara W
    Laryngoscope; 2019 Sep; 129(9):2082-2086. PubMed ID: 30604435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of Salvage Therapy in Isolated Regional Recurrence in Head and Neck Squamous Cell Carcinoma.
    Giger R; Fink R; Demattè M; Visini M; Elicin O; Anschuetz L
    Laryngoscope; 2021 Jan; 131(1):67-72. PubMed ID: 32057106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachytherapy after salvage surgery in cases with large isolated cervical recurrence of squamous cell carcinoma in the previously irradiated neck.
    Miroir J; Biau J; Saroul N; Moreira JF; Russier M; Lapeyre M
    Head Neck; 2016 Sep; 38(9):E2490-4. PubMed ID: 27061855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the risks and benefits before salvage surgery for recurrent head and neck squamous cell carcinoma.
    Locatello LG; Mastronicola R; Cortese S; Beulque E; Salleron J; Gallo O; Dolivet G
    Eur J Surg Oncol; 2021 Jul; 47(7):1718-1726. PubMed ID: 33549376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
    Head Neck; 2018 Apr; 40(4):728-739. PubMed ID: 29272056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?
    Saba NF; Mendenhall WM; Hutcheson K; Suárez C; Wolf G; Ferlito A
    Cancer; 2018 Nov; 124(21):4163-4164. PubMed ID: 30289965
    [No Abstract]   [Full Text] [Related]  

  • 39. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
    J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.